Get in touch
We have the right people
to develop the right solution
for the right therapy.
Photo of the Genomate Health teamPhoto of the Genomate Health teamPhoto of the Genomate Health team
Istvan Petak, MD, PhD, Founder and CEO of Genomate Health
Istvan Petak, MD, PhD
CEO, CSO & Founder
Dr. Istvan Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies with 25+ years of experience. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC). He started his molecular pathology and signal transduction therapy career at Semmelweis University and St. Jude Children's Research Hospital (Memphis, TN). His main achievements are exploring the role of apoptotic pathways in individual drug sensitivity, pioneering molecular companion diagnostics of the EGFR gene in 2003, and implementing NGS (next-generation sequencing) in precision oncology in 2008. He is the lead inventor of a novel computational method, published in 2021, for standardized, personalized treatment recommendations that has won numerous recognitions from organizations, including DIGITALEUROPE and ASCO.
Irving Levy, President and COO of Genomate Health
Irving Levy, CPA
Advisor - Finance & Administration
Mr. Levy is an accomplished entrepreneur, financial leader, and philanthropist with a 40-year career. He currently serves as President of Genomate Health, Inc. and Executive Director of the Foundation for Jewish Philanthropies. As a founding member of Exigence Group, a physician practice management start-up, Mr. Levy’s financial expertise led to remarkable growth, culminating in a $120 million expansion and exit in seven years in a sale to TeamHealth, a prominent public company owned by Blackstone Private Equity. Mr. Levy actively invests in early-stage enterprises as a General Partner in Impact Capital LLC, Buffalo Capital Partners LLC, and CPB Holdings Solutions, LLC.Mr. Levy was a Director and Partner of a Top 100 US public accounting firm, specializing in tax, healthcare, and entrepreneurial advisory services.

Mr. Levy’s extensive board involvement showcases his leadership capabilities and commitment to making a positive impact on the community.
Ioana Stupariu, LLM
Chief of Staff & Head of Legal
Ms. Stupariu is a technology regulation expert, with 15 years of experience in project management and operations and academic background in international business law. She founded ReadyTech Consulting, a boutique consultancy focused on providing regulatory, legal & compliance support to SMEs and is now an advisor for multiple technology driven startups in the region. Her professional portfolio also includes being Country Data Protection Officer for a large automotive company (responsible for 8 legal entities and 19.000 employees) and assistant professor of EU and International Law for 400- law student cohorts. Her PhD research at Central European University, Columbia Law School and China University of Political Science and Law allowed her to study applied privacy and technology in depth.
As a project and event manager, she has organized over 100 international events. She founded and coordinated an entrepreneurship social inclusion program for youth with thousands of beneficiaries (YouthBank Romania), and then an international academic network with members in 15 European countries and managed a team of 50 members (
Sean Khozin, MD, MPH, Advisor on Medical Affairs & Regulatory Strategy of Genomate Health
Sean Khozin, MD, MPH
Advisor on Medical Affairs & Regulatory Strategy
Dr. Sean Khozin is a globally recognized oncologist, data scientist, and physician-executive with extensive experience in therapeutic development and AI applications in biomedical research. As the founder of Phyusion and Senior Partner at Braven, he focuses on advancing innovations at the nexus of biology, technology, and AI. Previously, he was the CEO of CancerLinQ, the Global Head of Data Strategy at Johnson & Johnson, and a founding member of the US FDA’s Oncology Center of Excellence in addition to serving as the founding executive director of INFORMED, FDA’s first science and technology incubator. Dr. Khozin is the cofounder of the technology company Hello Health and founder of SKMD, a multidisciplinary network of clinics utilizing telemedicine and remote monitoring tools to improve patient outcomes. He is a Research Affiliate at MIT and  started his clinical research work at the US National Cancer Institute developing molecular profiling strategies in thoracic malignancies.

Dr. Khozin’s  board appointments include the Society for Translational Oncology, Alliance for AI in Healthcare, Digital Medicine Society, and the CEO Roundtable on Cancer’s Life Sciences Council.
At Genomate Health, our leadership team is made up of industry leaders, senior innovators, and smart advisory specialists who are passionate about making a positive impact in the world.
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Abstract picture of cancer tumour by Genomate Health
With their combined decades of experience in healthcare, technology, and business, our team is dedicated to transforming cancer care and improving outcomes for all patients.
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Let’s outsmart cancer.
If you are looking for a challenging and fulfilling career that makes a difference in the world, join us at Genomate Health and be a part of a team that is revolutionizing cancer treatment.
Explore Open Roles